Tumor Debulking Plus Chemotherapy for Multiorgan Metastatic Colorectal Cancer—Reply

Дата публикации: 18-08-2026 00:00:00

In Reply We appreciate the comments raised by Dr Adam and colleagues; their comments do not undermine the outcome of the ORCHESTRA study. We fully acknowledge the role of debulking surgery in more limited metastatic disease confined to the liver.

Схожие новости

#	Наименование новости	Тональность	Информативность	Дата публикации
1	Tumor Debulking Plus Chemotherapy for Multiorgan Metastatic Colorectal Cancer	0	8.63	18-08-2026
2	Tumor Debulking Plus Chemotherapy for Multiorgan Metastatic Colorectal Cancer	0	8.42	18-08-2026
3	Circulating Tumor DNA Status and Adjuvant Chemotherapy in Resected Colorectal Liver Metastases	0	7	03-07-2026
4	Blood Test May Help Identify Which Colorectal Cancer Patients with Liver Metastases Are Most Likely to Benefit from Chemotherapy After Surgery	0	7	03-07-2026
5	Effect of Neoadjuvant Therapy on Postoperative Complications in Colorectal Cancer: A Multicenter Prospective Propensity-Matched Cohort Study	0	5	16-07-2026
6	Blood test may help identify which colorectal cancer patients most likely to benefit from chemotherapy after surgery	0	5	06-07-2026
7	The mechanism of dietary factors regulating intestinal flora in alleviating the defecation dysfunction symptoms after sphincter-saving surgery for rectal cancer: A pilot study	0	15.98	20-08-2026
8	Omission of Axillary Dissection Following Nodal Downstaging With Neoadjuvant Chemotherapy	0	11.16	01-06-2024
9	Preoperative High-Dose Corticosteroids in Digestive Cancer Surgery	0	9.7	19-08-2026

Классификация: . Схожих патентов: 0. Схожих новостей: 9. Тональность: 0. Информативность: 6.33. Источник: jamanetwork.com.